Platelets enhance thrombin generation at sites of vascular injury by exposing phosphatidylserine during necrosis-like cell death. Anoctamin 6 (Ano6) is required for Ca 2 þ -dependent phosphatidylserine exposure and is defective in patients with Scott syndrome, a rare bleeding disorder. Ano6 may also form Cl À channels, though the role of Cl À fluxes in platelet procoagulant activity has not been explored. We found that Cl À channel blockers or removal of extracellular Cl À inhibited agonist-induced phosphatidylserine exposure. However, this was not due to direct inhibition of Ca 2 þ -dependent scrambling since Ca 2 þ ionophore-induced phosphatidylserine exposure was normal. This implies that the role of Ano6 in Ca 2 þ À dependent PS exposure is likely to differ from any putative function of Ano6 as a Cl À channel. Instead, Cl À channel blockade inhibited agonistinduced Ca 2 þ entry. Importantly, Cl À channel blockers also prevented agonist-induced membrane hyperpolarization, resulting in depolarization. We propose that Cl À entry through Cl À channels is required for this hyperpolarization, maintaining the driving force for Ca 2 þ entry and triggering full phosphatidylserine exposure. This demonstrates a novel role for Cl À channels in controlling platelet death and procoagulant activity. The central role of blood platelets in arterial thrombosis critically depends on their ability to promote localized thrombin generation.
1 High, sustained Ca 2 þ signals trigger necrotic cell death in platelets resulting in phosphatidylserine (PS) exposure in the outer leaflet of the plasma membrane. 2 Platelet PS forms a procoagulant surface that accelerates thrombin generation. It is currently believed that sustained intracellular Ca 2 þ signalling activates a nonspecific phospholipid 'scramblase' while inhibiting an inward aminophospholipid translocase ('flippase').
Ano6 (gene TMEM16F) is a key regulator of calciumdependent PS exposure. 3 Loss-of-function mutations in TMEM16F have been identified in two Scott syndrome patients, 3, 4 who have defective calcium-dependent PS exposure in platelets, erythrocytes and B lymphocytes. 5 However, how Ano6 contributes to PS scrambling is not clear. 6 Several groups have shown that Ano6 acts as a Cl À channel regulated by Ca 2 þ or cell volume. [7] [8] [9] [10] However, it is not immediately clear how PS exposure could be directly regulated by Cl À conductance. In this study, we have used platelets to test whether Cl À channels in principle can regulate Ca 2 þ -dependent PS exposure. We find that Cl À channel blockers do not affect PS exposure in response to a Ca 2 þ ionophore, implying that Cl À conductances are not necessary for platelet PS exposure. However, we also found that Cl À channel blockers reduce PS exposure in response to physiological platelet activators. Cl À channels are required for plasma membrane hyperpolarization in stimulated platelets, which in turn is required for sustained Ca 2 þ signalling. These data demonstrate a novel role for Cl À channels in platelet death and procoagulant activity.
Results
When platelets were co-stimulated by thrombin and collagenrelated peptide (CRP, an agonist of GPVI (glycoprotein VI)), a substantial fraction exposed PS on their surface, as detected by annexin V binding (Figures 1a and b Each inhibitor significantly reduced thrombin-plus-CRPinduced annexin V binding (Figure 1a ), indicating that Cl The role of Cl À channels in thrombin generation in plateletrich plasma was determined by the calibrated automated thrombogram (CAT) method. 15 Platelets were stimulated with CRP, and thrombin generation was initiated with tissue factor and CaCl 2 . Pre-treatment with Cl À channel blockers significantly reduced and slowed thrombin generation, indicating an important physiological role for these channels (Figures 1c-e) .
The Cl À channel blockers did not significantly inhibit thrombin-induced P-selectin expression (a marker of a-granule secretion). Thrombin-induced a IIb b 3 activation was not affected by T16Ainh-A01 and CaCCinh-A01 but was partially reduced by NPPB. Another commonly used Cl À channel blocker, DIDS, substantially reduced P-selectin expression and almost abolished a IIb b 3 activation, suggesting that it may have substantial off-target effects, and so was not used further in this study ( Figure 2 ). The greater effect of NPPB on peak thrombin generation may reflect its additional effect on a IIb b 3 activation as signalling through a IIb b 3 is reported to regulate thrombin generation. [16] [17] [18] In contrast to their inhibition of thrombin-plus-CRP-induced PS exposure, the Cl À channel blockers did not substantially inhibit PS exposure induced by the Ca 2 þ ionophore, A23187 ( Figure 3 ). This suggests that Cl À channels may regulate Ca 2 þ signalling rather than the exposure of PS in response to a sustained increase in intracellular Ca channels. 19 Cl À channel blockers had no effect on thrombinplus-CRP-induced Ca 2 þ signalling when EGTA was added to chelate extracellular Ca 2 þ , indicating that intracellular Ca 2 þ release is unaffected (Figure 4e ). In contrast, divalent cation entry, as monitored by Mn 2 þ quench, was substantially inhibited (Figure 4f ), suggesting that Cl À fluxes regulate Ca 2 þ entry. Several platelet Ca 2 þ entry channels have been described including store-operated Ca 2 þ entry, involving Orai1, 20, 21 and TRPC-dependent, store-independent Ca 2 þ entry. 22, 23 Electrophysiological recordings have demonstrated that Orai1 and TRPCs are sensitive to changes in membrane potential. 24, 25 Depolarization reduces Ca 2 þ entry through these channels, whereas hyperpolarization promotes Ca 2 þ entry. Cl À fluxes are likely to affect the membrane potential. We monitored membrane potential by using the potentialsensitive fluorescent dye, DiBAC 4 (3), which shows a decrease in fluorescence upon hyperpolarization from the resting potential, whereas depolarization gives an increase in fluorescence. 26 When platelets were stimulated with thrombinplus-CRP, DiBAC 4 (3) fluorescence initially decreased, indicating hyperpolarization, followed by a small, gradual increase in fluorescence (Figure 4g ). When Cl À channels were blocked the early hyperpolarization was completely lost (Figures 4g and h) , and an underlying depolarization was revealed. The same effect was seen in Cl À -free medium (Figure 4h ). These data indicate that the early hyperpolarization is dependent on Cl À entry through Cl À channels.
Discussion
Although Ano6 is critically involved in Ca 2 þ -dependent PS exposure, 3, 27 how it does this is not known. Several groups have shown that Ano6 can act as a Cl À channel in a range of cells. 7, 14 If Ano6 is acting as a Cl À channel in platelets, then Conversely, it has been proposed that Ano6 is in fact a small conductance cation channel, 27 in which case the identity of the platelet Cl À channel remains to be discovered. Importantly, our data suggest that PS scrambling activity does not directly require Cl À entry. Although our data show that Cl À channels are important in platelet PS exposure, blocking Cl À conductance does not completely abolish agonist-induced PS exposure and platelet-dependent thrombin generation and has no effect on A23187-induced PS exposure. A similar conclusion has recently been reached in lymphocytes by Kmit et al., 14 who found that Cl À channel blockers had no effect on ionomycin-induced PS exposure. This contrasts with the loss-of-function mutations in TMEM16F and absent Ca 2 þ -dependent PS exposure in Scott syndrome patients. Importantly, this implies that the role of Ano6 in Ca 2 þ -dependent PS exposure in platelets and lymphocytes is likely to be different to any putative function of Ano6 as a Cl À channel.
Materials and Methods Materials. A23187, NPPB, DIDS and T16Ainh-A01 were from Tocris (Bristol, UK). CaCCinh-A01 was from Calbiochem (Nottingham, UK). Fura-2 AM (acetoxymethylester) was from Teflabs (Austin, TX, USA). FITC-annexin V was from Abcam (Cambridge, UK). FITC-confjugated anti-CD62P antibody and FITC-PAC-1 antibody were from BD Biosciences (Oxford, UK). DiBAC 4 (3) was from Life Technologies (Paisley, UK). Cross-linked collagen-related peptide (CRP) was from Prof. Richard Farndale (Department of Biochemistry, University of Cambridge, UK). Tissue factor (Dade Innovin) was from Seimens Healthcare (Camberley, UK). The fluorescent thrombin substrate, Z-Gly-Gly-Arg-AMC HCl, was from Bachem (Weil am Rhein, Germany). The thrombin calibrator was from Diagnostica Stago (Theale, UK). All other reagents were from Sigma (Poole, UK), and were of analytical grade.
Platelet preparation. Blood was obtained from healthy drug-free volunteers with approval from the local Research Ethics Committee of the University of Bristol, UK; informed, written consent was obtained in accordance with the Declaration of Helsinki. All donors reported that they had not taken any drugs known to affect platelet function (e.g., aspirin) for 10 days before donation. Fura-2-loaded human platelets were prepared essentially as previously described. 19 Platelets were resuspended in modified Tyrodes-HEPES (135 mM NaCl, 3 mM KCl, 12 mM 10 mM Hepes, 5 mM glucose, 1 mM MgCl 2 and 0.02 U/ml apyrase (grade VII), pH 7.3) to a density of 1 Â 10 8 /ml. Unless indicated otherwise, all experiments were performed in the presence of 1 mM extracellular CaCl 2 . Thrombin generation. Thrombin generation was monitored in normalized PRP (1.5 Â 10 8 platelets/ml). PRP was stimulated with CRP for 5 min. Thrombin generation was triggered with tissue factor/CaCl 2 cleavage of the substrate Z-Gly-Gly-Arg-AMC HCl measured by the thrombogram method in a Fluoroskan Ascent microplate reader at 371C. Thrombin concentrations were determined by using a Thrombin Calibrator (Stago) following correction for the inner filter effect and substrate consumption as described by Hemker et al.
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Flow cytometry. Annexin V-FITC was used to detect surface PS exposure. FITC-conjugated anti-CD62P antibody was used to monitor a-granule secretion and FITC-conjugated PAC-1 antibody was used to monitor a IIb b 3 activation. Platelets (5 Â 10 7 /ml) were stimulated in the presence of CaCl 2 (1 mM) for 10 min then diluted in Tyrode's-HEPES buffer containing 2 mM CaCl 2 and analysed immediately. Fluorescence was detected by flow cytometry, with platelets gated by their forward and side scatter profile Analysis of 20 000 platelets was performed Calcium measurements. Fura-2 fluorescence from magnetically stirred cuvettes was monitored at 371C using a Hitachi F-4500 (Hitachi High-Technologies, Maidenhead, UK) spectrofluorimeter with fluorescence excitation made at 340 and 380 nm, and emission at 510 nm. The ratio of emissions (F 340 :F 380 ) was calibrated in terms of [Ca 2 þ ] i . 28 Calibrations were also performed in the presence of Cl À channel blockers to account for any effects on fura-2 fluorescence.
Mn 2 þ entry. Fura-2 fluorescence was excited at the isosbestic wavelength (359 nm) and emission detected at 510 nm. Autofluorescence was subtracted and fluorescence was expressed relative to the initial fluorescence (F/F 0 ). Mn 2 þ entry was detected as a quench of fura-2 fluorescence.
Membrane potential measurement. Platelet membrane potential was monitored with the potential-sensitive fluorescent dye, DiBAC 4 (3). Platelets were incubated with DiBAC 4 (3) (100 nM; 30 min) prior to stimulation. Fluorescence was excited at 490 nm and emission detected at 590 nm. Fluorescence was expressed relative to the initial value (F/F 0 ).
Data analyses.
Mean data are presented with standard errors; the number of replicates of each experiment, representing independent experiments from platelet preparations from different donors is reported in the figure legends. Data were analysed by one-way ANOVA, with Dunnett's test for multiple comparisons. Po0.05 was considered statistically significant.
